Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024

– Aberrant TRIM7 expression identified as a key driver of immune checkpoint blockade acquired resistance; inhibition of TRIM7 with small molecule inhibitors may prevent or reverse acquired...

Related Keywords

San Diego ,California ,United States ,San Diego Convention Center ,Texas ,North Carolina ,Conor Richardson ,George Fromm ,Taylor Schreiber ,Exchange Commission ,Nasdaq ,Shattuck Labs Inc ,Cancer Cell ,Chief Executive Officer ,Dysregulated Interferon Responsiveness ,Chief Scientific Officer ,Drug Discovery ,New Therapies ,Presentation Number ,Shattuck Labs ,Agonist Redirected Checkpoint ,Annual Report ,Safe Harbor ,Private Securities Litigation Reform Act ,Media Contact ,Markets ,